• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2022 年 7 月至 8 月,在纽约市猴痘病毒传播高峰期的血清学证据

Serological Evidence of Mpox Virus Infection During Peak Mpox Transmission in New York City, July to August 2022.

机构信息

Bureau of Hepatitis, HIV, and STI, New York City Department of Health and Mental Hygiene, Queens, New York, USA.

Multinational Mpox Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

出版信息

J Infect Dis. 2024 Nov 15;230(5):1102-1109. doi: 10.1093/infdis/jiae181.

DOI:10.1093/infdis/jiae181
Abstract

BACKGROUND

The extent to which infections may have been undetected in an epicenter of the 2022 mpox outbreak is unknown.

METHODS

A serosurvey (July and August 2022) assessed the seroprevalence and correlates of mpox infection among a diverse sample of asymptomatic patients with no prior mpox diagnoses and no known histories of smallpox or mpox vaccination. We present seropositivity stratified by participant characteristics collected via survey.

RESULTS

Two-thirds of 419 participants were cismen (281 of 419), of whom 59.1% (166 of 281) reported sex with men (MSM). The sample also included 109 ciswomen and 28 transgender/gender nonconforming/nonbinary individuals. Overall seroprevalence was 6.4% (95% confidence interval [CI], 4.1%-8.8%); 3.7% among ciswomen (95% CI, 1.0%-9.1%), 7.0% among cismen with only ciswomen partners (95% CI, 2.0%-11.9%), and 7.8% among MSM (95% CI, 3.7%-11.9%). There was little variation in seroprevalence by race/ethnicity, age group, HIV status, or number of recent sex partners. No participants who reported close contact with mpox cases were seropositive. Among participants without recent mpox-like symptoms, 6.3% were seropositive (95% CI, 3.6%-9.0%).

CONCLUSIONS

Approximately 1 in 15 vaccine-naive people in our study had antibodies to mpox during the height of the NYC outbreak, indicating the presence of asymptomatic infections that could contribute to ongoing transmission.

摘要

背景

在 2022 年猴痘疫情的中心,有多少感染可能未被发现尚不清楚。

方法

一项血清学调查(2022 年 7 月和 8 月)评估了无症状患者中猴痘感染的血清流行率及其相关因素,这些患者没有先前的猴痘诊断,也没有天花或猴痘疫苗接种的已知病史。我们根据通过调查收集的参与者特征,对血清阳性率进行分层。

结果

419 名参与者中有三分之二为男性(281 名),其中 59.1%(166 名)报告有男男性行为。该样本还包括 109 名女性和 28 名跨性别/性别不一致/非二进制个体。总血清阳性率为 6.4%(95%置信区间[CI],4.1%-8.8%);女性为 3.7%(95% CI,1.0%-9.1%),仅有女性性伴侣的男性为 7.0%(95% CI,2.0%-11.9%),男男性行为者为 7.8%(95% CI,3.7%-11.9%)。血清阳性率在种族/民族、年龄组、艾滋病毒状况或最近性伴侣数量方面差异不大。没有报告与猴痘病例密切接触的参与者呈血清阳性。在没有近期类似猴痘症状的参与者中,有 6.3%呈血清阳性(95% CI,3.6%-9.0%)。

结论

在我们的研究中,大约每 15 名未接种疫苗的人群中就有 1 人在纽约市疫情高峰期时对猴痘有抗体,表明存在无症状感染,这可能导致持续传播。

相似文献

1
Serological Evidence of Mpox Virus Infection During Peak Mpox Transmission in New York City, July to August 2022.2022 年 7 月至 8 月,在纽约市猴痘病毒传播高峰期的血清学证据
J Infect Dis. 2024 Nov 15;230(5):1102-1109. doi: 10.1093/infdis/jiae181.
2
A seroprevalence study indicates a high proportion of clinically undiagnosed MPXV infections in men who have sex with men in Berlin, Germany.一项血清流行率研究表明,在德国柏林,与男性发生性关系的男性中,临床未诊断的猴痘病毒感染比例较高。
BMC Infect Dis. 2024 Oct 14;24(1):1153. doi: 10.1186/s12879-024-10066-z.
3
Investigating seroprevalence of IgG antibodies against Monkeypox Virus (MPXV) in a cohort of people living with HIV (PLWH) in Rome, during the 2022 outbreak: Moving beyond traditional at-risk populations.调查 2022 年猴痘病毒 (MPXV) 在罗马 HIV 感染者 (PLWH) 队列中的 IgG 抗体血清阳性率:超越传统高危人群。
Travel Med Infect Dis. 2024 Nov-Dec;62:102757. doi: 10.1016/j.tmaid.2024.102757. Epub 2024 Sep 4.
4
Scenarios of future mpox outbreaks among men who have sex with men: a modelling study based on cross-sectional seroprevalence data from the Netherlands, 2022.未来男男性行为人群中猴痘疫情爆发情景:基于 2022 年荷兰横断面血清阳性率数据的建模研究。
Euro Surveill. 2024 Apr;29(17). doi: 10.2807/1560-7917.ES.2024.29.17.2300532.
5
Effectiveness of JYNNEOS Vaccine Against Diagnosed Mpox Infection - New York, 2022.2022 年美国纽约 JYNNEOS 疫苗对确诊猴痘感染的有效性
MMWR Morb Mortal Wkly Rep. 2023 May 19;72(20):559-563. doi: 10.15585/mmwr.mm7220a4.
6
Modifications to Sexual Behaviors Associated With Mpox (Monkeypox) Virus Transmission Among Persons Presenting for mpox Vaccination, Washington, DC, August-October, 2022.2022 年 8 月至 10 月,美国华盛顿特区,在因猴痘(猴痘病毒)疫苗接种而就诊的人群中,与猴痘病毒传播相关的性行为改变。
Sex Transm Dis. 2024 Jan 1;51(1):54-60. doi: 10.1097/OLQ.0000000000001889. Epub 2023 Oct 25.
7
Discordant performance of mpox serological assays.痘苗病毒血清学检测的不一致表现。
J Virol Methods. 2024 Sep;329:115004. doi: 10.1016/j.jviromet.2024.115004. Epub 2024 Aug 8.
8
Investigation of an Mpox Outbreak Affecting Many Vaccinated Persons in Chicago, Illinois-March 2023-June 2023.2023 年 3 月至 6 月,伊利诺伊州芝加哥市发生一起影响许多已接种疫苗者的猴痘疫情调查。
Clin Infect Dis. 2024 Jul 19;79(1):122-129. doi: 10.1093/cid/ciae181.
9
HIV infection in men who have sex with men, New York City Department of Health sexually transmitted disease clinics, 1990-1999: a decade of serosurveillance finds that racial disparities and associations between HIV and gonorrhea persist.1990 - 1999年纽约市卫生部门性传播疾病诊所中男男性行为者的艾滋病毒感染情况:十年血清监测发现艾滋病毒与淋病之间的种族差异及关联依然存在。
Sex Transm Dis. 2002 Feb;29(2):73-8. doi: 10.1097/00007435-200202000-00002.
10
Risk of Clade II Mpox Associated with Intimate and Nonintimate Close Contact Among Men Who Have Sex with Men and Transgender Adults - United States, August 2022-July 2023.与男男性行为者和跨性别成年人的亲密和非亲密密切接触相关的 II 型猴痘病毒(Clade II Mpox)风险-美国,2022 年 8 月至 2023 年 7 月。
MMWR Morb Mortal Wkly Rep. 2024 Oct 10;73(40):896-902. doi: 10.15585/mmwr.mm7340a2.

引用本文的文献

1
Serological Response to Mpox and Direct Virus Detection in Asymptomatic Patient Prior to the First Diagnosed Case: A Retrospective Study of the 2022 Montpellier Epidemic.首例确诊病例之前无症状患者对猴痘的血清学反应及病毒直接检测:2022年蒙彼利埃疫情的回顾性研究
J Med Virol. 2025 May;97(5):e70365. doi: 10.1002/jmv.70365.
2
Monkeypox Virus: WHO's Second Public Health Emergency of International Concern Within 2 Years.猴痘病毒:世界卫生组织在两年内发布的第二次国际关注的突发公共卫生事件
Microb Biotechnol. 2025 Apr;18(4):e70142. doi: 10.1111/1751-7915.70142.
3
Early Diagnosis and Monitoring of Adaptive Immune Response in a Cohort of Mild Mpox Patients During the 2022 Wave.

本文引用的文献

1
Prevalence of Undiagnosed Monkeypox Virus Infections during Global Mpox Outbreak, United States, June-September 2022.2022 年 6 月至 9 月全球猴痘疫情期间美国未诊断猴痘病毒感染的流行情况。
Emerg Infect Dis. 2023 Nov;29(11):2307-2314. doi: 10.3201/eid2911.230940. Epub 2023 Oct 13.
2
Effectiveness of JYNNEOS Vaccine Against Diagnosed Mpox Infection - New York, 2022.2022 年美国纽约 JYNNEOS 疫苗对确诊猴痘感染的有效性
MMWR Morb Mortal Wkly Rep. 2023 May 19;72(20):559-563. doi: 10.15585/mmwr.mm7220a4.
3
Profiling the acute phase antibody response against mpox virus in patients infected during the 2022 outbreak.
2022年疫情期间轻症猴痘患者队列中适应性免疫反应的早期诊断与监测
Microorganisms. 2025 Feb 6;13(2):355. doi: 10.3390/microorganisms13020355.
分析 2022 年暴发期间感染猴痘病毒患者的急性期抗体反应。
J Med Virol. 2023 Jun;95(6):e28851. doi: 10.1002/jmv.28851.
4
Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study - United States, August 19, 2022-March 31, 2023.JYNNEOS 疫苗预防猴痘的有效性估计:多司法管辖区病例对照研究-美国,2022 年 8 月 19 日至 2023 年 3 月 31 日。
MMWR Morb Mortal Wkly Rep. 2023 May 19;72(20):553-558. doi: 10.15585/mmwr.mm7220a3.
5
Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States.美国 JYNNEOS 疫苗对猴痘疾病的有效性。
N Engl J Med. 2023 Jun 29;388(26):2434-2443. doi: 10.1056/NEJMoa2215201. Epub 2023 May 18.
6
Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals.感染和接种人群中补体依赖性猴痘病毒中和抗体。
Cell Host Microbe. 2023 Jun 14;31(6):937-948.e4. doi: 10.1016/j.chom.2023.05.001. Epub 2023 May 5.
7
Mpox outbreak among men who have sex with men in Amsterdam and Rotterdam, the Netherlands: no evidence for undetected transmission prior to May 2022, a retrospective study.荷兰阿姆斯特丹和鹿特丹男男性行为人群中的猴痘疫情:2022 年 5 月之前不存在未被发现的传播的证据,一项回顾性研究。
Euro Surveill. 2023 Apr;28(17). doi: 10.2807/1560-7917.ES.2023.28.17.2200869.
8
JYNNEOS Vaccination Coverage Among Persons at Risk for Mpox - United States, May 22, 2022-January 31, 2023.2022 年 5 月 22 日至 2023 年 1 月 31 日期间,美国有感染风险人群的 JYNNEOS 疫苗接种率。
MMWR Morb Mortal Wkly Rep. 2023 Mar 31;72(13):342-347. doi: 10.15585/mmwr.mm7213a4.
9
Evidence of Mpox Virus Infection Among Persons Without Characteristic Lesions or Rash Presenting for First Dose of JYNNEOS Vaccine-District of Columbia, August 2022.2022 年 8 月,哥伦比亚特区在无特征性皮损或皮疹的 JYNNEOS 疫苗首剂接种者中出现猴痘病毒感染证据。
Clin Infect Dis. 2023 Jul 26;77(2):298-302. doi: 10.1093/cid/ciad145.
10
Kinetics of viral DNA in body fluids and antibody response in patients with acute Monkeypox virus infection.急性猴痘病毒感染患者体液中病毒DNA的动力学及抗体反应
iScience. 2023 Mar 17;26(3):106102. doi: 10.1016/j.isci.2023.106102. Epub 2023 Feb 1.